Skip to content
OpenCapital
Get started

MSCI MSCI Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$47.13+56.3%
CB Financial Services logo
CB Financial ServicesCBFV
$22.65-0.4%
Microbot Medical logo
Microbot MedicalMBOT
$1.65+66.7%
WaFd, Inc. logo
WaFd, Inc.WAFD
$7.53+36.9%
American Battery Technology Company logo
American Battery Technology CompanyABAT
$1.90—
WSFS Financial logo
WSFS FinancialWSFS
$0.00-100%

Other financials

Income statement

See full
Revenue$850.8M+14.1%
Gross profit$709.0M+16.4%
Operating income$456.9M+21.2%
Net income$406.0M+40.7%
EPS (diluted)$5.53+49.1%

Balance sheet

See full
Cash & equivalents$385.3M+6.8%
Total debt$6.6B+40.1%
Total equity-$2.8B-189%
Total assets$5.5B+3.8%

Cash flow

See full
Operating cash flow$306.8M+1.7%
CapEx$2.8M-75.9%
Free cash flow$304.0M+4.8%

Valuation

See full
Market cap$40.77B+0.3%
Enterprise value$46.96B+4.2%
P/E30.9×-3.6×
P/S12.6×-1.0×

Profitability

See full
Gross margin82.9%+0.7pp
Operating margin55.4%+1.8pp
Net margin40.7%+1.7pp
FCF margin48.3%-1.8pp

Returns & leverage

See full
Return on equity113.8%—
Debt / equity6.8×—
Current ratio0.9×0.0×

Where this comes from

Reported directly by MSCI in its filing.

Tagged under the XBRL concept us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue.

The official record: MSCI’s 10-K, filed February 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about MSCI's share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MSCI's share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price?
MSCI (MSCI) reported share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price of $665.73 in Q4 2025.
What is the long-term trend for MSCI's share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price?
Over 3 years (2022 to 2025), MSCI's share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price has grown at a 6.6% compound annual growth rate (CAGR), from $549.83 to $665.73.
What does share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price mean?
This is the weighted average price at which nonvested options were granted to employees. It reflects the cost basis for future equity awards that are currently in the vesting period. This metric helps investors understand the potential future dilution cost based on current grant prices.